2024 Q2 Form 10-K Financial Statement
#000155479524000164 Filed on July 02, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $34.79K | $52.89K | |
YoY Change | -14.96% | -3122.29% | |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $34.79K | $52.88K | $181.2K |
YoY Change | -14.97% | 477.92% | -60.4% |
Operating Profit | -$34.79K | -$181.2K | |
YoY Change | -14.97% | -60.4% | |
Interest Expense | $8.558K | -$15.39K | $125.2K |
YoY Change | -75.11% | -57.53% | -35.98% |
% of Operating Profit | |||
Other Income/Expense, Net | -$8.558K | $0.00 | -$217.7K |
YoY Change | -93.42% | -100.0% | -83.16% |
Pretax Income | -$43.34K | -$274.0K | -$398.9K |
YoY Change | -74.65% | -74.76% | -77.21% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$43.34K | -$274.0K | -$398.9K |
YoY Change | -74.65% | -74.76% | -77.21% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.00 | -$0.01 | |
COMMON SHARES | |||
Basic Shares Outstanding | 31.98M shares | 30.08M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $7.210K | $4.300K | $4.300K |
YoY Change | -74.91% | -85.12% | -85.12% |
Cash & Equivalents | $7.211K | $4.298K | $4.300K |
Short-Term Investments | |||
Other Short-Term Assets | $4.200K | $6.500K | $6.500K |
YoY Change | 5.26% | -18.55% | -18.55% |
Inventory | |||
Prepaid Expenses | $4.200K | $6.500K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $11.41K | $10.80K | $10.80K |
YoY Change | -65.13% | -70.72% | -70.72% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $11.41K | $10.80K | $10.80K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $11.41K | $10.80K | $10.80K |
YoY Change | -65.13% | -70.72% | -70.72% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $5.000K | $0.00 | |
YoY Change | -13.21% | -100.0% | |
Accrued Expenses | $15.55K | $13.03K | $13.03K |
YoY Change | -62.95% | -55.67% | -55.67% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $170.6K | $180.4K | $180.4K |
YoY Change | 82.82% | 190.92% | 190.92% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $217.6K | $193.4K | $193.4K |
YoY Change | -37.82% | 5.66% | 5.66% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $217.6K | $193.4K | $193.4K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $217.6K | $193.4K | $193.4K |
YoY Change | -37.82% | 5.66% | 5.66% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$17.56M | -$17.52M | |
YoY Change | 1.57% | 2.33% | |
Common Stock | $31.98K | $30.24K | |
YoY Change | 29.49% | 22.46% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$206.1K | -$182.6K | -$182.6K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $11.41K | $10.80K | $10.80K |
YoY Change | -65.13% | -70.72% | -70.72% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$43.34K | -$274.0K | -$398.9K |
YoY Change | -74.65% | -74.76% | -77.21% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$23.49K | -$33.30K | -$117.1K |
YoY Change | -6.64% | 25.09% | -17.55% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
Cash From Investing Activities | $0.00 | $0.00 | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $26.40K | 25.00K | $92.50K |
YoY Change | 5.6% | -16.67% | -38.33% |
NET CHANGE | |||
Cash From Operating Activities | -$23.49K | -33.30K | -$117.1K |
Cash From Investing Activities | 0.000 | 0.000 | |
Cash From Financing Activities | $26.40K | 25.00K | $92.50K |
Net Change In Cash | $2.913K | -8.300K | -$24.60K |
YoY Change | -1943.67% | -345.56% | -408.26% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$23.49K | -$33.30K | -$117.1K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2024 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2024 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2024 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001570937 | |
CY2024 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
usd | |
CY2024Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
usd | |
CY2024Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
usd | |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
usd | |
CY2024Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
usd | |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q1 | us-gaap |
Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
|
shares | |
CY2024 | us-gaap |
Exploration Expense
ExplorationExpense
|
usd | |
CY2023 | ATAO |
Gain Loss On Conversion Of Debt1
GainLossOnConversionOfDebt1
|
usd | |
CY2024 | us-gaap |
Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1
DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1
|
usd | |
CY2024 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2024 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2024 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2024 | ATAO |
Stock Issued Accounts Payable During Period Value Other
StockIssuedAccountsPayableDuringPeriodValueOther
|
usd | |
CY2023 | ATAO |
Stock Issued Accrued Compensation During Period Value Other
StockIssuedAccruedCompensationDuringPeriodValueOther
|
usd | |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17515410 | usd |
CY2024Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
usd | |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
||
CY2024 | ATAO |
Conversion Price Maximum
ConversionPriceMaximum
|
||
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
pure | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
pure | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | |
CY2024 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2024Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2024 | dei |
Document Type
DocumentType
|
10-K | |
CY2024 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024 | dei |
Entity File Number
EntityFileNumber
|
333-190235 | |
CY2024 | dei |
Entity Registrant Name
EntityRegistrantName
|
ALTAIR INTERNATIONAL CORP. | |
CY2024 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
99-0385465 | |
CY2024 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
322 North Shore Drive | |
CY2024 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Building 1B, Suite 200 | |
CY2024 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Pittsburgh | |
CY2024 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
PA | |
CY2024 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
15212 | |
CY2024 | dei |
City Area Code
CityAreaCode
|
412 | |
CY2024 | dei |
Local Phone Number
LocalPhoneNumber
|
770-3140 | |
CY2024 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2024 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2024 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2024 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2024 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2024 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q3 | dei |
Entity Public Float
EntityPublicFloat
|
8024044 | usd |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
31975852 | shares |
CY2024 | dei |
Auditor Name
AuditorName
|
Fruci & Associates II, PLLC | |
CY2024 | dei |
Auditor Firm
AuditorFirmId
|
5525 | |
CY2024 | dei |
Auditor Location
AuditorLocation
|
Spokane, Washington | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4298 | usd |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
28897 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
6500 | usd |
CY2023Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
7980 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
10798 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
36877 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
10798 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
36877 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3500 | usd |
CY2023Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
25500 | usd |
CY2024Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
14165 | usd |
CY2023Q1 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
14165 | usd |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
13029 | usd |
CY2023Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
3889 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
5210 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
91100 | usd |
CY2024Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
166234 | usd |
CY2023Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
47844 | usd |
CY2023Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
88169 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
193428 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
183067 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
193428 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
183067 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30238686 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30238686 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24692459 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24692459 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
30239 | usd |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
24693 | usd |
CY2024Q1 | us-gaap |
Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
|
58938 | shares |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
17243603 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
16945642 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17515410 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17116525 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-182630 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-146190 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10798 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
36877 | usd |
CY2023 | us-gaap |
Exploration Expense
ExplorationExpense
|
10890 | usd |
CY2024 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
48000 | usd |
CY2023 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
318000 | usd |
CY2024 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
33600 | usd |
CY2023 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
32500 | usd |
CY2024 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
99578 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
96150 | usd |
CY2024 | us-gaap |
Operating Expenses
OperatingExpenses
|
181178 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
457540 | usd |
CY2024 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-181178 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-457540 | usd |
CY2024 | us-gaap |
Interest Expense
InterestExpense
|
125169 | usd |
CY2023 | us-gaap |
Interest Expense
InterestExpense
|
195528 | usd |
CY2024 | ATAO |
Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
|
4002 | usd |
CY2023 | ATAO |
Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
|
38444 | usd |
CY2024 | ATAO |
Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
|
120069 | usd |
CY2023 | ATAO |
Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
|
-1003598 | usd |
CY2024 | us-gaap |
Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1
NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
|
-205737 | usd |
CY2023 | us-gaap |
Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1
NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
|
6000 | usd |
CY2024 | ATAO |
Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
|
10872 | usd |
CY2023 | ATAO |
Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
|
138127 | usd |
CY2024 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-217707 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1292809 | usd |
CY2024 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-398885 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-1750349 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-398885 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1750349 | usd |
CY2024 | ATAO |
Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
|
-0.02 | |
CY2023 | ATAO |
Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
|
-0.07 | |
CY2024 | ATAO |
Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
|
25605919 | shares |
CY2023 | ATAO |
Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
|
24234937 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15451 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1566208 | usd |
CY2023 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
70000 | shares |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
22500 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1750349 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-146190 | usd |
CY2024 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
270845 | usd |
CY2024 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
3126668 | shares |
CY2024 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
86600 | usd |
CY2024 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
5000 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-398885 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-182630 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-398885 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1750349 | usd |
CY2024 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
110920 | usd |
CY2023 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
184389 | usd |
CY2024 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
3600 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
270000 | usd |
CY2024 | ATAO |
Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
|
4002 | usd |
CY2023 | ATAO |
Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
|
38444 | usd |
CY2024 | ATAO |
Gain Loss On Conversion Of Debt1
GainLossOnConversionOfDebt1
|
205737 | usd |
CY2024 | ATAO |
Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
|
10872 | usd |
CY2023 | ATAO |
Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
|
138127 | usd |
CY2023 | us-gaap |
Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1
DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1
|
-6000 | usd |
CY2024 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
120069 | usd |
CY2023 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
-1003598 | usd |
CY2024 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
7980 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-7980 | usd |
CY2024 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3500 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-12000 | usd |
CY2024 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
56000 | usd |
CY2023 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
41500 | usd |
CY2024 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-14248 | usd |
CY2023 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-11139 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-117099 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-142020 | usd |
CY2024 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
92500 | usd |
CY2023 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
100000 | usd |
CY2023 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
50000 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
92500 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
150000 | usd |
CY2024 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-24599 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
7980 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
28897 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20917 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4298 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
28897 | usd |
CY2024 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
|
65108 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
|
247364 | usd |
CY2023 | ATAO |
Stock Issued Accounts Payable During Period Value Other
StockIssuedAccountsPayableDuringPeriodValueOther
|
22500 | usd |
CY2024 | ATAO |
Stock Issued Accrued Compensation During Period Value Other
StockIssuedAccruedCompensationDuringPeriodValueOther
|
76500 | usd |
CY2024 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84B_eus-gaap--UseOfEstimates_zjQDY3y1Gg0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_z9Lmz0EQIqrb">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p> | |
CY2024 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zFdx7P3C09x7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zozMeX44acOe">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p> | |
CY2024 | ATAO |
Note Holder
NoteHolder
|
EROP Enterprises (2) | |
CY2023Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
88169 | usd |
CY2024 | us-gaap |
Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
|
35872 | usd |
CY2024 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-3972 | usd |
CY2024 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
86921 | usd |
CY2024 | ATAO |
Eliminate Derivate For Change Of Conversion Feature
EliminateDerivateForChangeOfConversionFeature
|
-206990 | usd |
CY2022Q4 | us-gaap |
Share Price
SharePrice
|
0.051 | |
CY2023 | ATAO |
Conversion Price Minimum
ConversionPriceMinimum
|
0.015 | |
CY2023 | ATAO |
Conversion Price Maximum
ConversionPriceMaximum
|
0.056 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.8753 | pure |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
2.0008 | pure |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0464 | pure |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0494 | pure |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P0Y1M17D | |
CY2023 | ATAO |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
|
P0Y11M26D | |
CY2023Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 25 reverse stock split and reduced its authorized shares of common stock from 5,000,000,000 (5 billion) to | |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
|
500000000 | shares |
CY2024 | ATAO |
Common Stock Reclassed To Additional Paid In Capital
CommonStockReclassedToAdditionalPaidInCapital
|
592619 | usd |
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
40000 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.25 | |
CY2024 | ATAO |
Aggregate Fair Value Of Warrants
AggregateFairValueOfWarrants
|
180000 | usd |
CY2024Q1 | ATAO |
Warrants Estimates Used Stock Price
WarrantsEstimatesUsedStockPrice
|
4.50 | |
CY2024 | ATAO |
Warrants Estimates Used Exercise Price
WarrantsEstimatesUsedExercisePrice
|
0.25 | |
CY2024 | ATAO |
Warrants Estimates Used Risk Free Rate
WarrantsEstimatesUsedRiskFreeRate
|
0.0157 | pure |
CY2024 | ATAO |
Warrants Estimates Used Volatility
WarrantsEstimatesUsedVolatility
|
7.3546 | pure |
us-gaap |
Officers Compensation
OfficersCompensation
|
22000 | usd | |
CY2023 | us-gaap |
Officers Compensation
OfficersCompensation
|
34000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
0 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
18000 | usd |
CY2022 | ATAO |
Stock Issued During Period Shares Related Parties2
StockIssuedDuringPeriodSharesRelatedParties2
|
400000 | shares |
CY2022 | ATAO |
Stock Issued During Period Price Per Share Related Parties2
StockIssuedDuringPeriodPricePerShareRelatedParties2
|
0.90 | |
CY2022 | ATAO |
Stock Issued Related Party Non Cash Stock Compensation Expense2
StockIssuedRelatedPartyNonCashStockCompensationExpense2
|
360000 | usd |
CY2023 | ATAO |
Conversion Of Payables Into Common Stock Amount
ConversionOfPayablesIntoCommonStockAmount
|
22500 | usd |
CY2023 | ATAO |
Conversion Of Payables Into Common Stock Shares
ConversionOfPayablesIntoCommonStockShares
|
70000 | shares |
CY2024 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
5000 | usd |
CY2024Q1 | ATAO |
Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
|
0 | usd |
CY2023Q1 | ATAO |
Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
|
7500 | usd |
CY2024 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
83800 | usd |
CY2023 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
367600 | usd |
CY2024 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
83800 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
367600 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3678000 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3594000 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3678000 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3594000 | usd |
CY2024Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
3678000 | usd |